Drugs / HCQ
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04841148 | Jun 2021 → Jul 2027 expected | breast cancer | Abramson Cancer Center at Penn Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HCQ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04841148 ↗ |
| Action | Inhibit | “autophagy (inhibited by HCQ)” NCT04841148 ↗ |